Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deflazacort in Dysferlinopathies
NCT00527228Phase 3Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Sep 2003
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of deflazacort in dysferlinopathy, sponsored by Ludwig Maximilian University of Munich. Started Sep 2003; status: completed.
02
Drugs
deflazacort
03
Conditions
dysferlinopathy
Beyond the preview
Go deeper on NCT00527228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527228.